BioMarin Announces Fourth Quarter and Record Full-year 2019 Financial Results

Go back to BioMarin Announces Fourth Quarter and Record Full-year 2019 Financial Results
BioMarin Pharmaceuticals, Inc. (NASDAQ: BMRN) Delayed: 64.63 --0 (-0%)
Previous Close $64.63    52 Week High $108.96 
Open $64.63    52 Week Low $62.12 
Day High $64.63    P/E N/A 
Day Low $64.63    EPS $-1.27 
Volume 48